Summary

Summary

Contract Unique IdentifierDO1.SLCNTR.592236 
Contract referenceInst. Nac. de Cancer-2021-00908 
Contract description:MEDICAMENTOS CITOSTATICOS y PALIATIVOS 
Goods 
Contract Start:
13/01/2022 09:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End:
16/03/2022 09:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Legally Binding?
 
Contract StateAccepted 

Contracting Company Identification

Contracting Company Identification


Supplier Company Identification

Supplier Company Identification



Object Info

Object Info

DGCP-08-ProcesosExcepcion 
Inst. Nac. de Cancer-CCC-PEEX-2021-0011 
MEDICAMENTOS CITOSTATICOS y PALIATIVOS 
MEDICAMENTOS CITOSTATICOS y PALIATIVOS 
LOGISTICA 
KETLE SANCHEZ_EXT 
GoodsDominicana 
6,401,160 Dominican Pesos 

Financial & Delivery Conditions

Financial & Delivery Conditions

Delivery optionsTransporte incluido 
Contract Start Date
07/01/2022 09:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End Date
10/03/2022 09:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
nstituto Nacional del Cáncer Rosa Emilia Sánchez Pérez de Tavares Av. Correa y Cidrón, Esq. Rafael A. Sánchez Ravelo, Zona Universitaria DO 

Payment Conditions

Payment Conditions

Payment Method 
Invoice Payment Deadline90 days 

Contract Comments

Contract Comments

REQUERIMIENTO AM0166-2021 SOLICITADO POR LOGISTICA . ENTREGA PARCIAL YUDERCA MONTERO

 
 
 1 
DO1.PCCNTR.1194930 ContractData Container
 1.1  
-
    
Total sin descuentosValor del descuentoTotal ITBISTotal Otros ImpuestosSubtotalTotal
6,401,160.000.000.000.006,408,360.006,401,160.00
    
ReferenciaCódigo UNSPSCCuenta presupuestariaDescripciónCantidadUnidadPrecio unitario estimadoPrecio unitarioImporte moneda orig. s/ITBIS% Desc.Descuento moneda originalMonto Gravado (Obras)% ITBISITBIS Moneda Original% Otros ImpuestosOtros impuestos moneda originalPrecio total estimadoValor del precio de respuesta
    
23
51111713 - Alemtuzumab
2.3.4.1.01ANASTRAZOL (ARIMIDEX) 1 MG4,200UD305303.571,275,000.000.000.000.001,281,000.001,275,000.00
    
24
51111713 - Alemtuzumab
2.3.4.1.01BICALUTAMIDA (CASODEX) 50 MG, COMPRIMIDO840UD355353.57297,000.000.000.000.00298,200.00297,000.00
    
25
51111713 - Alemtuzumab
2.3.4.1.01PROZOLADEX AMP 10.8 MG INY.48UD21,85021,8501,048,800.000.000.000.001,048,800.001,048,800.00
    
26
51111713 - Alemtuzumab
2.3.4.1.01PROZOLADEX AMP. 3.63 MG INY.240UD7,8507,8501,884,000.000.000.000.001,884,000.001,884,000.00
    
27
51111713 - Alemtuzumab
2.3.4.1.01FULVESTRANT 250 MG, INY. X 2 JERING36UD48,26048,2601,737,360.000.000.000.001,737,360.001,737,360.00
    
28
51111713 - Alemtuzumab
2.3.4.1.01TAMOXIFENO 20 MG (NOLVADEX-D) COMP3,000UD5353159,000.000.000.000.00159,000.00159,000.00
 
Contract Document Template

Contract Document Template

DescriptionFile Name
Download
Download
Download
Download

Budget Settings

Budget Settings

Investment
General Source
6,401,160.00 DOP
 DOP
AccountValueAnnual Availability
2.3.4.1.016,401,160.00  DOP----View
Payment Calendar
IDDescriptionValueMonthYear
1  MEDICAMENTOS CITOSTATICOS y PALIATIVOS6,401,160.00  DOPDiciembre2021
Certificate of Appropriation
YearCertificate CodeCertificate VersionCertificate ValueCertificate StateCertificate Link
2021164011606,401,160.00  DOP